Advances in Pharmacotherapy: New Drugs Hospitalists Should Know - On Demand 2026
Bedside insights meet breakthrough science as recent FDA approvals reshape inpatient decisions. Guided by hospitalists with pharmacy roots, you’ll review pivotal data, learn practical dosing nuances, evaluate efficacy and safety in real cases, and synthesize pearls that optimize acute care. Leave ready to apply evidence with confidence on rounds—and design safer, smarter treatment plans.
Availability
On-Demand
Expires on Apr 05, 2029
Credit Offered
0.75 CME Credit
0.75 ABIM-MOC Point
0.75 Participation Credit
  • Overview
  • Faculty
  • Accreditation
  • Recommended
Learning Objectives
After completing this activity, learners should be able to:
  1. Summarize the mechanisms, indications, and supporting clinical evidence for newly FDA-approved drugs.
  2. Summarize the available data on efficacy and safety for these agents in clinical practice.
  3. Identify the appropriate patient populations and clinical scenarios in which these medications may be used within hospital medicine.
  4. Compare these new pharmacotherapies with existing standards of care, emphasizing distinctions in dosing, monitoring requirements, and adverse-effect profiles.
  5. Apply principles of evidence-based decision-making to effectively integrate these agents into inpatient treatment and discharge medication plans.
Faculty
  • Niti Patel, MD, PharmD
  • Thomas Chen, MD, PharmD
Faculty Disclosures
The individuals in control of content for this activity have no relevant relationships with ACCME-defined ineligible companies to disclose unless listed here. Any relevant relationships were mitigated prior to the start of this activity.
CME Credit Statement
The Society of Hospital Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Credit Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75  MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

IOS App Download Powered By